Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2024

Caitlin E. Cox

September 03, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

Michael O'Riordan

July 01, 2024

Presentation EuroPCR 2024

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Presenter: Ling Tao

May 15, 2024

News Conference News EuroPCR 2024

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Yael L. Maxwell

May 15, 2024

Presentation EuroPCR 2024

Methodological Insight: REC-CAGEFREE II Trial

Presenter: Robert Byrne

May 14, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Michael O'Riordan

March 14, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Daily News

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

Michael O'Riordan

January 30, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

Michael O'Riordan

January 03, 2024

Presentation Cardiovascular Interventions 2023

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

Presenter: Ajay J. Kirtane

November 10, 2023

Advertisement

Top Coronary Artery Disease News in 2024

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

TCTMD’s Top 10 Most Popular Stories for August 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

ORBITA-STAR Highlights Variability in Symptom Changes Post-PCI

One-month DAPT followed by 5-month Ti - cagrelor monotherapy in acute coronary syndromes with DCB - results from REC-CAGEFREE II

Stepwise DAPT De-escalation Shows Promise in DCB-Only PCI for ACS

Methodological Insight: REC-CAGEFREE II Trial

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Invasive Angio Adds Nothing to CCTA Alone for Risk Prediction: ISCHEMIA

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

Obstructive CAD Can Be Left Alone Before TAVI, Observational Data Suggest

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Five Years Post-PCI, Clopidogrel Monotherapy Holds Up in STOPDAPT-2

ICYMI: Drug Coated Balloons Have FINALLY Arrived: Here’s How I’m Going to Use Them!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content